REFERENCES
  1. Aluga, MA. Coronavirus disease 2019 (COVID-19) in Kenya: Preparedness, response and transmissibility. J Microbiol, Immun, and Infect. 2020; 53(5), 671. https://doi.org/10.1016/J.JMII.2020.04.011
  2. World Health Organization. Kenya - WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int › region › afro › country
  3. Hanssen DAT, Slaats M, Mulder M, Savelkoul PHM, van Loo IHM. Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples. Eur J Clin Microbiol Infect Dis. 2021;40:1695–703.
  4. Harritshøj LH, Gybel-Brask M, Afzal S, Kamstrup PR, Jørgensen CS, Thomsen MK, et al.Comparison of 16 serological SARS-CoV-2 immunoassays in 16 clinical laboratories. J Clin Microbiol. 2021;59:e02596–20.
  5. Cohen, J. (1960). A Coefficient of Agreement for Nominal Scales. Educational and Psychological Measurement, 20(1), 37–46. https://doi.org/10.1177/001316446002000104
  6. Lisboa Bastos M, Tavaziva G, Abidi SK, Campbell JR, Haraoui L-P, Johnston JC, et al.Diagnostic accuracy of serological tests for COVID-19: Systematic review and meta-analysis. BMJ. 2020;370:m2516.
  7. Ghaffari A, Meurant R, Ardakani A. COVID-19 serological tests: How well do they actually perform? Diagnostics (Basel). 2020 Jul 4;10(7):453. doi: 10.3390/diagnostics10070453. PMID: 32635444; PMCID: PMC7400479.
  8. Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020 Jul;75(7):1564-1581. doi: 10.1111/all.14364. PMID: 32396996; PMCID: PMC7272948.
  9. Hoffman T, Nissen K, Krambrich J, Rönnberg B, Akaberi D, Esmaeilzadeh M, Salaneck E, Lindahl J, Lundkvist Å. Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2. Infect Ecol Epidemiol. 2020 Apr 14;10(1):1754538. doi: 10.1080/20008686.2020.1754538. PMID: 32363011; PMCID: PMC7178815.
  10. Li G, Chen X, Xu A. Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med. 2003 Jul 31;349(5):508-9. doi: 10.1056/NEJM200307313490520. PMID: 12890855.
  11. Hsueh PR, Huang LM, Chen PJ, Kao CL, Yang PC. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin Microbiol Infect. 2004 Dec;10(12):1062-6. doi: 10.1111/j.1469-0691.2004.01009.x. PMID: 15606632; PMCID: PMC7129952.
  12. Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY, Li YM, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J. 2020 Aug 27;56(2):2001526. doi: 10.1183/13993003.01526-2020. PMID: 32398307; PMCID: PMC7236821.
  13. Fox T, Geppert J, Dinnes J, Scandrett K, Bigio J, Sulis G, et al. Antibody tests for identification of current and past infection with SARS‐CoV‐2. Cochrane Database of Systematic Reviews 2022, Issue 11. Art. No.: CD013652. DOI: 10.1002/14651858.CD013652.pub2. Accessed 24 August 2023.